Clinical trials recruiting for Radiotherapy Side Effect

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
  NCT05354596 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
  NCT04889924 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 60 locations
• Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
  NCT05724004 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
  NCT06311981 · Phase: Phase 2 · Ages: 75 Years and older · Sex: All (male and female) · 1 location
• Curatively Intended Thoracic Reirradiation
  NCT06950073 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
  NCT04612907 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).
  NCT04472845 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
  NCT03742687 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
  NCT06321653 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
  NCT05183074 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
  NCT06648148 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Omitting CTV for Primary Tumor in LS-SCLC
  NCT07008716 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Super-Hypofractionated Partial Breast Irradiation
  NCT06615466 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 74 Years · Sex: Female · 1 location
• Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
  NCT06758830 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
  NCT05786742 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 95 Years · Sex: Male · 1 location
• Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
  NCT05762900 · Phase: Phase 2 · Ages: 35 Years and older · Sex: Female · 1 location

Related conditions

Trials recruiting for Radiotherapy Side Effect often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Radiotherapy Side Effect trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.